C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.480
+0.020 (0.81%)
At close: Nov 25, 2025, 4:00 PM EST
2.470
-0.010 (-0.40%)
After-hours: Nov 25, 2025, 4:54 PM EST
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $240.35 million as of November 25, 2025. Its market cap has decreased by -43.63% in one year.
Market Cap
240.35M
Enterprise Value
100.11M
1-Year Change
-43.63%
Ranking
Category
Stock Price
$2.48
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $240.35M, a decrease of -68.90%. That is a compound annual growth rate of -20.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 238.41M | -6.18% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |